IFI30 and breast carcinoma: Intriguingly, however, IFI30 RNA expression is associated with better patient survival in breast cancer (12) and diffuse large B cell lymphomas (DLBCL) (14) while GPB1 RNA is associated with better patient survival in melanoma (20) but poorer prognosis in human glioblastoma (21).